CellaVision AB (publ) (FRA:C26)

CellaVision AB Statistics

Total Valuation

CellaVision AB has a market cap or net worth of EUR 390.04 million. The enterprise value is 378.66 million.

Market Cap	390.04M
Enterprise Value	378.66M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	May 7, 2025

Share Statistics

Current Share Class	23.85M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	19.82M

Valuation Ratios

The trailing PE ratio is 28.81 and the forward PE ratio is 23.70.

PE Ratio	28.81
Forward PE	23.70
PS Ratio	5.80
PB Ratio	5.29
P/TBV Ratio	14.06
P/FCF Ratio	22.73
P/OCF Ratio	21.11
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.23, with an EV/FCF ratio of 22.07.

EV / Earnings	27.97
EV / Sales	5.54
EV / EBITDA	18.23
EV / EBIT	21.12
EV / FCF	22.07

Financial Position

The company has a current ratio of 3.19, with a Debt / Equity ratio of 0.04.

Current Ratio	3.19
Quick Ratio	2.28
Debt / Equity	0.04
Debt / EBITDA	0.13
Debt / FCF	0.16
Interest Coverage	30.75

Financial Efficiency

Return on equity (ROE) is 19.35% and return on invested capital (ROIC) is 15.05%.

Return on Equity (ROE)	19.35%
Return on Assets (ROA)	12.30%
Return on Invested Capital (ROIC)	15.05%
Return on Capital Employed (ROCE)	21.45%
Revenue Per Employee	293,840
Profits Per Employee	59,115
Employee Count	219
Asset Turnover	0.75
Inventory Turnover	2.00

Taxes

In the past 12 months, CellaVision AB has paid 3.56 million in taxes.

Income Tax	3.56M
Effective Tax Rate	20.81%

Stock Price Statistics

The stock price has decreased by -28.84% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-28.84%
50-Day Moving Average	15.54
200-Day Moving Average	16.70
Relative Strength Index (RSI)	62.21
Average Volume (20 Days)	327

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CellaVision AB had revenue of EUR 67.29 million and earned 13.54 million in profits. Earnings per share was 0.57.

Revenue	67.29M
Gross Profit	46.32M
Operating Income	17.66M
Pretax Income	17.09M
Net Income	13.54M
EBITDA	19.38M
EBIT	17.66M
Earnings Per Share (EPS)	0.57

Balance Sheet

The company has 13.90 million in cash and 2.70 million in debt, giving a net cash position of 11.20 million.

Cash & Cash Equivalents	13.90M
Total Debt	2.70M
Net Cash	11.20M
Net Cash Per Share	n/a
Equity (Book Value)	73.69M
Book Value Per Share	3.09
Working Capital	25.00M

Cash Flow

In the last 12 months, operating cash flow was 18.48 million and capital expenditures -1.32 million, giving a free cash flow of 17.16 million.

Operating Cash Flow	18.48M
Capital Expenditures	-1.32M
Free Cash Flow	17.16M
FCF Per Share	n/a

Margins

Gross margin is 68.83%, with operating and profit margins of 26.24% and 20.12%.

Gross Margin	68.83%
Operating Margin	26.24%
Pretax Margin	25.40%
Profit Margin	20.12%
EBITDA Margin	28.80%
EBIT Margin	26.24%
FCF Margin	25.50%

Dividends & Yields

This stock pays an annual dividend of 0.23, which amounts to a dividend yield of 1.52%.

Dividend Per Share	0.23
Dividend Yield	1.52%
Dividend Growth (YoY)	18.98%
Years of Dividend Growth	n/a
Payout Ratio	39.44%
Buyback Yield	n/a
Shareholder Yield	1.52%
Earnings Yield	3.47%
FCF Yield	4.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7